Passage Bio
PASG
PASG
48 hedge funds and large institutions have $21.3M invested in Passage Bio in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $31.4M → $21.3M (-$10.1M)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Holders
48
Holding in Top 10
2
Calls
$4K
Puts
–
Top Buyers
| 1 | +$132K | |
| 2 | +$77K | |
| 3 | +$65.8K | |
| 4 |
Morgan Stanley
New York
|
+$43.2K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$16.9K |
Top Sellers
| 1 | -$643K | |
| 2 | -$81.8K | |
| 3 | -$60.4K | |
| 4 |
Millennium Management
New York
|
-$59.9K |
| 5 |
AC
Annandale Capital
Dallas,
Texas
|
-$51K |